Factors influencing outcome following radio-chemotherapy for oesophageal cancer

Radiotherapy and Oncology

Volumn 40, Issue 1, 1996, Pages 31-43

  Denham, J W ^a   Burmeister, B H ^b   Lamb, D S ^c   Spry, N A ^d   Joseph, D J ^d   Hamilton, C S ^a   Yeoh, E ^e   O'Brien, P ^a   Walker, Q J ^b  

^a NEWCASTLE MATER HOSPITAL   (Australia)

^b Queensland Radium Institute   (Australia)

^c WELLINGTON HOSPITAL   (New Zealand)

^d GEELONG HOSPITAL   (Australia)

^e ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Chemotherapy; Oesophageal cancer; Patterns of failure; Prognostic factors; Radio chemotherapy; Radiotherapy; Surgery

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 2642675592     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-8140(96)01762-8     Document Type: Article

References (19)

1. [1] Al-Sarraf, M. The current status of combined modality treatment containing chemotherapy in patients with esophageal cancer. Int. J. Radiat. Oncol. Biol. Phys. 19: 813-815, 1990.
2. [2] Bonett, A., Roder, D. and Esterman, A. Epidemiology of cancer in South Australia: incidence, mortality and survival 1977 to 1988. Incidence and mortality 1988 (analysed by type and geographical location). Lutheran Publishing House, Adelaide, 1990.
3. [3] Burmeister, B.H., Denham, J.W., O'Brien, M., Jamieson, G.G., Gill, P.G., Devitt, P., Yeoh, E., Hamilton, C.S., Ackland, S.P., Lamb, D.S., Spry, N.A., Joseph, D.J., Atkinson, C. and Walker, Q.J. Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicentre study. Int. J. Radiat. Oncol. Biol. Phys. 32: 997-1006, 1995.
4. [4] Caplan, R.J., Pajak, T.F. and Cox, J.D. Analysis of the probability and risk of cause-specific failure. Int. J. Radiat. Oncol. Biol. Phys. 29: 1183-1186, 1994.
5. [5] Coia, L.R., Engstrom, P.F., Paul, A.R., Stafford, P.M. and Hanks, G.E. Longterm results of infusional 5-FU, Mitomycin-C, and radiation as primary management of esophageal carcinoma. Inc J. Radiat. Oncol. Biol. Phys. 20: 29-36, 1991.
6. [6] De-Ren, S. Ten-year follow-up of esophageal cancer treated by radical radiation therapy: analysis of 869 patients. Int. J. Radiat. Oncol. Biol. Phys. 16: 329-334, 1989.
7. [7] Denham, J.W., Gill, P.G., Jamieson, G.G., Hetzel, D., Devitt, P., Fitch, R., Britten-Jones, R., Gibson, G.E., Abbott, R.L., Hecker, R., Williams, R.S. and Olweny, C.L. Preliminary experience using a combined modality approach to the management of oesophageal cancer. Med. J. Aust. 148: 9-13, 1987.
8. [8] Earlam, R. and Cunha-Melo, J.R. Oesophageal squamous cell carcinoma. I. A critical review of surgery. Br. J. Surg. 6: 381-390, 1980.
9. [9] Earlam, R. and Cunha-Melo, J.R. Oesophageal squamous cell carcinoma. II. A critical review of radiotherapy. Br. J. Surg. 67: 457-461, 1980.
10. [10] Gelfland, G.A.J. and Finley, R.J.F. Quality of life with carcinoma of the esophagus. World J. Surg. 18: 399-405, 1994.
11. [11] Gill, P.G., Denham, J.W., Jamieson, G.G., Devitt, P.H., Yeoh, E. and Olweny, C. Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery. J. Clin. Oncol. 10: 1037-1043, 1992.
12. [12] Gill, P.G., Jamieson, G.G., Denham, J., Devitt, P.G., Ahmad, A., Yeoh, E. and Jones, A. M. Treatment of adenocarcinoma of the cardia with synchronous chemotherapy and radiotherapy. Br. J. Surg. 77: 1020-1023, 1990.
13. [13] Herskovic, A., Martz, K., Al-Sarraf, M., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L. and Emami, B. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N. Engl. J. Med. 326: 1593-1631, 1992.
14. [14] Kavanagh, B., Anscher, M., Leopold, K., Deutsch, M., Gaydica, E., Dodge, R., Allen, K., Allen, D., Staub, W., Montana, G., Crawford, J. and Wolfe, W. Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990. Int. J. Radiat. Oncol. Biol. Phys. 24: 633-642, 1992.
15. [15] MacKean, J., Burmeister, B.H., Lamb, D.S. and Denham, J.W. Concurrent chemo-radiation for oesophageal cancer - factors influencing myelotoxicity. Australas. Radiol. 1995. (in press)
16. [16] Muller, J.M., Erasmi, H., Stelzner, M. et al. Surgical therapy of oesophageal carcinoma. Br. J. Surg. 77: 845-847, 1990.
17. [17] Newaishy, G.A., Read, G.A., Duncan, W. and Kerr, G.R. Results of radical radiotherapy of squamous cell carcinoma of the oesophagus. Clin. Radiol. 33: 347-352, 1982.
18. [18] Walsh, T.N., Noonan, N., Keeling, P.W.N., Breslin, B. and Hennessy, T.P.J. Chemotherapy, radiotherapy and surgery versus surgery alone for oesophageal squamous carcinoma. Br. J. Surg. 80: 1993.
19. [19] Whittington, R., Coia, L.R., Haller, D.G., Rubenstein, J.H. and Rosato, E.F. Adenocarcinoma of the esophagus and esophagogastric junction: the effects of single and combined modalities on the survival and patterns of failure following treatment. Int. J. Radiat. Oncol. Biol. Phys. 19: 593-603, 1990.